A composite glandular/exocrine-endocrine carcinoma of the gastrointestinal tract is characterized by the co-existence of two adjacent, but histologically-distinct tumors in an organ. Composite glandular/exocrine-endocrine carcinomas are a special type of tumor comprised of common adenocarcinomas and neuroendocrine components that account for at least one-third of the entire tumor area. Composite tumors have been reported in a range of organs, but are relatively rare in the stomach. We report a case of a composite neuroendocrine carcinoma with an adenocarcinoma of the stomach (mixed exocrine-endocrine carcinoma), which was misdiagnosed as a giant submucosal tumor preoperatively based on esophagogastroduodenoscopy and a contrast-enhanced axial computed tomographic scan.
Introduction
Human cancers exhibiting a combination of conventional (glan- We report a case of a composite neuroendocrine carcinoma with adenocarcinoma of the stomach (mixed exocrine-endocrine carcinoma), which was misdiagnosed as a giant gastric submucosal tumor preoperatively by esophagogastroduodenoscopy (EGD) and contrast-enhanced axial computed tomographic (CT) scan. By immunohistochemical staining of the neuroendocrine carcinoma component, the tumor was identified as a composite neuroendocrine carcinoma with adenocarcinoma of the stomach. We report this rare case with a review of the literature.
Case Report
A 62-year-old woman underwent EGD, abdominal CT and abdominal ultrasonography as part of an evaluation for epigastric discomfort. Her past medical and family histories were unremarkable. The physical examination on admission, routine blood tests, and urine analysis were also unremarkable. The levels of tumor markers were within the reference range, as follows: carcinoembryonic antigen (CEA), 5.21 ng/ml (normal, ≤8 ng/ml); CA 19-9, 10.49 U/ml (normal, ≤37 U/ml); and CA 72-4, 0.289 ng/ml (normal, ≤6.9 ng/ml).
The EGD revealed a huge, well-defined, fungating, submucosal mass with eccentric ulceration characterized by an ill-defined margin in lesser curvature of the gastric antrum (Fig. 1 ). An EGD biopsy was not performed because a biopsy is not generally recommended for the diagnosis of gastric submucosal tumors. A contrastenhanced axial CT scan demonstrated a huge, solid, ovoid, heterogeneous, exophytic mass measuring approximately 15×10 cm in the pre-pyloric antrum of the stomach with several metastasis into the lymphatic glands around the stomach was observed (Fig. 2) . A diagnosis of a giant submucosal tumor of the stomach with lymph node metastasis was made, and a radical subtotal gastrectomy with D2 lymph node dissection was subsequently performed.
Grossly, a diffuse submucosal bulging mass was noted in the surgically-resected stomach. The mass-measure 17×15×6.5 cm, and had an intact mucosa, with the exception of a small polypoid nodule with a central ulcerated umbilication measuring 1.5×1 cm.
On sectioning, the cut surface of the mass showed a diffuse, geographic, hemorrhagic, necrotic area with a cleft-like cystic change and grayish-brown solid area which infiltrated to the surrounding omental fat tissue.
Microscopically, the tumor was comprised of a conventional adenocarcinoma with anaplastic glandular nests and a neuroendocrine carcinoma with central necrosis (Fig. 3) . The glandular carcinoma was confined to the mucosa and submucosa, the neuroendocrine carcinoma had invaded into the serosa and the lymphatic glands. Two of 39 lymph nodes had metastases, and lymphatic and perineural invasion were observed. Immunohistochemically, the tumor cells exhibited immunopositivity for chromogranin A and synaptophysin, but negativity for CD56, CD117, CD34, and SMA.
The neuroendocrine carcinoma components showed strong immunopositivity for chromogranin A, but were negative for the adenocarcinoma component (Fig. 4) .
The post-operative course was uneventful and the patient was discharged on the 9th postoperative day.
Discussion
Submucosal tumors refer to tumors that exist below the mucosal layer and protrude into the lumen in a hemispherical or spherical (Fig. 4) .
With the exception of the appendix, only rare instances of composite tumors have been detected in the esophagus, stomach, etoposide after gastrectomy has been reported to result in reduction of liver metastasis by 96% and lung metastasis by 81%, chemotherapy has recently been recommended to be administered following gastrectomy; however, the efficacy has not been fully verified due to the low incidence. (15) In summary, we initially misdiagnosed the tumor as a giant gastric submucosal tumor by EGD and contrast-enhanced axial CT scan, and subsequently performed surgical resection. However, in retrospect, metastasis into the lymphatic glands around the stomach was observed in the pre-operative contrast-enhanced axial CT scan, and eccentric ulceration with an ill-defined margin was noted on EGD, which could have been diagnosed as metastasis into the lymphatic glands around the stomach secondary to gastric cancer. Therefore, if a submucosal tumor is large and eccentric ulceration with ill-defined margins is observed with lymphatic gland metastasis around the stomach, an adenocarcinoma, and although extremely rare, a composite glandular-endocrine carcinoma containing a conventional carcinoma should be taken into consideration in the differential diagnosis.
